Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 3
2008 1
2009 6
2010 2
2011 5
2012 3
2013 3
2014 4
2015 5
2016 3
2017 9
2018 19
2019 11
2020 8
2021 13
2022 8
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Results by year

Filters applied: . Clear all
Page 1
Advances in Systemic Therapy in Pancreatic Cancer.
Yu KH. Yu KH. Hematol Oncol Clin North Am. 2024 Apr 3:S0889-8588(24)00029-7. doi: 10.1016/j.hoc.2024.03.002. Online ahead of print. Hematol Oncol Clin North Am. 2024. PMID: 38575456 Review.
Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of "Second Hit" in Germline BRCA1-Associated Pancreatic Ductal Adenocarcinoma.
Zheng-Lin B, Rainone M, Varghese AM, Yu KH, Park W, Berger M, Mehine M, Chou J, Capanu M, Mandelker D, Stadler ZK, Birsoy O, Jairam S, Yang C, Li Y, Wong D, Benhamida JK, Ladanyi M, Zhang L, O'Reilly EM. Zheng-Lin B, et al. Among authors: yu kh. Mol Diagn Ther. 2022 Nov;26(6):645-653. doi: 10.1007/s40291-022-00614-1. Epub 2022 Sep 30. Mol Diagn Ther. 2022. PMID: 36178671 Free PMC article.
Clinico-genomic Characterization of ATM and HRD in Pancreas Cancer: Application for Practice.
Park W, O'Connor CA, Bandlamudi C, Forman D, Chou JF, Umeda S, Reyngold M, Varghese AM, Keane F, Balogun F, Yu KH, Kelsen DP, Crane C, Capanu M, Iacobuzio-Donahue C, O'Reilly EM. Park W, et al. Among authors: yu kh. Clin Cancer Res. 2022 Nov 1;28(21):4782-4792. doi: 10.1158/1078-0432.CCR-22-1483. Clin Cancer Res. 2022. PMID: 36040493 Free PMC article.
Concurrent Germline BRCA1/2 and Mismatch Repair Mutations in Young-Onset Pancreatic and Colorectal Cancer: The Importance of Comprehensive Germline and Somatic Characterization to Inform Therapeutic Options.
Ozer M, Ranganathan M, Lecomte N, Schvartzman JM, Walch HS, Chatila WK, Hong J, Carlo MI, Walsh MF, Sheehan M, Mandelker D, Ceyhan-Birsoy O, Maio A, Kemel Y, Iacobuzio-Donahue CA, O'Reilly EM, Yu KH. Ozer M, et al. Among authors: yu kh. JCO Precis Oncol. 2022 Jun;6:e2100560. doi: 10.1200/PO.21.00560. JCO Precis Oncol. 2022. PMID: 35675575 Free PMC article. No abstract available.
Circulating tumor and invasive cell expression profiling predicts effective therapy in pancreatic cancer.
Yu KH, Park J, Mittal A, Abou-Alfa GK, El Dika I, Epstein AS, Ilson DH, Kelsen DP, Ku GY, Li J, Park W, Varghese AM, Chou JF, Capanu M, Cooper B, Bartlett A, McCarthy D, Sangar V, McCarthy B, O'Reilly EM. Yu KH, et al. Cancer. 2022 Aug 1;128(15):2958-2966. doi: 10.1002/cncr.34269. Epub 2022 Jun 1. Cancer. 2022. PMID: 35647938 Free PMC article. Clinical Trial.
IL-32 Supports the Survival of Malignant T Cells in Cutaneous T-cell Lymphoma.
Yu KK, Smith NP, Essien SV, Teague JE, Vieyra-Garcia P, Gehad A, Zhan Q, Crouch JD, Gerard N, Larocca C, Wolf P, LeBoeuf NR, Tawa M, Kupper TS, Villani AC, Clark RA. Yu KK, et al. J Invest Dermatol. 2022 Aug;142(8):2285-2288.e2. doi: 10.1016/j.jid.2022.01.009. Epub 2022 Feb 7. J Invest Dermatol. 2022. PMID: 35143819 Free PMC article. No abstract available.
100 results